Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
ADT Intensification: The Evidence You Can’t Afford to Miss
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Targeting PTEN: Why It Matters
Case: Implementing ADT Intensification in mHSPC
Molecular Profiling in mHSPC: Informing Treatment Selection
EHA 2026: Long-Term Zanubrutinib Outcomes
Alessandra Tedeschi, MD
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
Maria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
De Novo mHSPC: Recognizing the Patients Who Need More
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
Robert D. Suh, MD
Ashwin Basavaraj, MD
Mary Salvatore, MD, MBA
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
David T. Rubin, MD
Michael Dolinger, MD, MBA
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
Understanding the Microbiome’s Role in IBD Management
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.